Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Oct 1, 2020
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Purchase
Common Stock
2020-09-29$15.00/sh+5,000$75,000→ 672,500 total - Purchase
Common Stock
2020-09-30$15.30/sh+5,000$76,500→ 677,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.20 to $15.30, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.